Lv1
10 积分 2022-10-28 加入
Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance
2小时前
待确认
LBA52 Sintilimab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced or metastatic esophageal squamous cell cancer: First results of the phase III ORIENT-15 study
1个月前
已完结
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Perioperative Nivolumab in Resectable Lung Cancer
1个月前
已完结
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
1个月前
已完结
Neoadjuvant Targeted Therapy in Resectable Non-Small Cell Lung Cancer: Current and Future Perspectives
1年前
已完结
myCAFs are better than yours: targeting myofibroblasts potentiates immunotherapy
1年前
已完结
myCAFs are better than yours: targeting myofibroblasts potentiates immunotherapy
1年前
已完结
Predictive genetic biomarkers in immune checkpoint inhibitors for non-small-cell lung cancer
1年前
已完结
唾液酸化和岩藻糖基化在肺癌中的研究进展
1年前
已完结
皖公网安备34019202002308
